Effect of Docetaxel Combined with Cisplatin Preoperative Neoadjuvant Chemotherapy for Stage III NSCLC
The aim of this study was to investigate the effect of docetaxel plus cisplatin preoperative neoadjuvant chemotherapy in stage III non-small cell lung cancer (NSCLC). It was an analytical study carried out from May 2013 to May 2017. Eightytwo patients with stage III NSCLC were divided into Group A a...
Gespeichert in:
| Veröffentlicht in: | Journal of the College of Physicians and Surgeons--Pakistan 2019-12, Vol.29 (12), p.1230-1231 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The aim of this study was to investigate the effect of docetaxel plus cisplatin preoperative neoadjuvant chemotherapy in stage III non-small cell lung cancer (NSCLC). It was an analytical study carried out from May 2013 to May 2017. Eightytwo patients with stage III NSCLC were divided into Group A and B according to a random number table (n=41). Group A received neoadjuvant chemotherapy with docetaxel plus cisplatin before surgery. Group B underwent surgical treatment after preoperative examination. Compared with group B,operation time of group A was shorter (p |
|---|---|
| ISSN: | 1022-386X 1681-7168 |
| DOI: | 10.29271/jcpsp.2019.12.1230 |